Journals / Turkish Journal of Endocrinology and Metabolism / 2018 / Cilt: 22 - Sayı: 3

Nodular Thyroid Disease and Papillary Thyroid Carcinoma in Functional Pituitary Adenomas

Fonksiyonel Hipofiz Adenomlarında Nodüler Tiroid Hastalığı ve Papiller Tiroid Kanseri

Pages
158–166
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Nodular thyroid disease frequency was higher in pati- ents with acromegaly (69%) compared to those with prolactinoma (36%) or Cushing’s disease (34%) (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Increased frequency of nodular thyroid disease has been reported in acromegalic patients.
📊
Key Findings & Data:Recent studies have also demonstrated an increased co-existence of nodular thyroid di- sease with Cushing’s disease and prolactinoma.
💡
Conclusion & Impact:Results: Nodular thyroid disease frequency was higher in pati- ents with acromegaly (69%) compared to those with prolactinoma (36%) or Cushing’s disease (34%) (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Increased frequency of nodular thyroid disease has been reported in acromegalic patients. Recent studies have also demonstrated an increased co-existence of nodular thyroid di- sease with Cushing’s disease and prolactinoma. In this study, we evaluated the frequency and outcomes of nodular thyroid disease in each type of functional pituitary adenoma. Material and Methods: A total of 232 patients diagnosed with acromegaly (n=138), prolactinoma (n=59) or Cushing’s disease (n=35) were included in this retrospective observational study. The frequency of nodular thyroid disease, fine-needle aspiration re- sults, and the frequency of papillary thyroid carcinoma were com- pared in each group. Factors related to nodule development were evaluated in functional pituitary adenoma patients with or without nodules. Results: Nodular thyroid disease frequency was higher in pati- ents with acromegaly (69%) compared to those with prolactinoma (36%) or Cushing’s disease (34%) (p

Özet

Amaç: Akromegaliklerde nodüler tiroid hastalığı sık görülmesine rağmen, Cushing hastalığı ve prolaktinomalarında artmış sıklığını gösteren yayınlar mevcuttur. Bu nedenle; her bir fonksiyonel hipofiz adenomu, nodüler tiroid hastalığı görülme sıklıkları ve takip sonuçları açısından karşılaştırdık. Gereç ve Yöntemler: Bu çalışma, fonksiyonel hipofiz adenomu tanılı toplam 232 hastanın (138 akromegali, 59 prolaktinoma ve 35 Cushing hastalığı) dahil edildiği retrospektif gözlemsel bir çalışmadır. Her bir fonksiyonel hipofiz adenomu için nodüler tiroid hastalığı görülme sıklıkları, tiroid ince iğne aspirasyon biyopsisi, cerrahi sonuçları ve papiller tiroid kanseri görülme sıklıkları kaydedilmiştir. Nodülü olan ve olmayan hastalar nodül gelişimiyle ilişkili olabilecek parametreler açısından karşılaştırılmıştır. Bulgular: Nodüler tiroid hastalığı; akromegaliklerde (%69), prolaktinomalar (%36) ve CH olanlara (%34) göre daha yüksek (p

🔖

Cite This Article

YARMAN, S., DOĞANŞEN, S. Ç., TANRIKULU, S., YALIN, G. Y. (2022). Nodular Thyroid Disease and Papillary Thyroid Carcinoma in Functional Pituitary Adenomas. Turkish Journal of Endocrinology and Metabolism, Cilt: 22 - Sayı: 3, 158–166. https://ajindex.com/articles/605447

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A, Lowenstein A. Thyroid nodules in acromegaly. Arq Bras Endocrinol Metabol. 2012;56:300-304.
  2. Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf). 1997;46:545-549.
  3. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodinedeficient area. Eur J Endocrinol. 2009;161:599- 605. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev. 2001;22:631-656.
  4. Schmid D, Behrens G, Jochem C, Keimling M, Leitzmann M. Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2013;28:945-958.
  5. Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, Hollenbeck A, Ward MH. Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid. 2011;21:957-963.
  6. Yasar HY, Ertuğrul O, Ertuğrul B, Ertuğrul D, Sahin M. Insulin resistance in nodular thyroid disease. Endocr Res. 2011;36:167-174. 38.Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid. 2008;18:461-464.
  7. Anil C, Akkurt A, Ayturk S, Kut A, Gursoy A. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism. 2013;62:970-975.
  8. Wüster C, Steger G, Schmelzle A, Gottswinter J, Minne HW, Ziegler R. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res. 1991;23:131-134.
  9. Dauksiene D, Petkeviciene J, Klumbiene J, Verkauskiene R, Vainikonyte-Kristapone J, Seibokaite A, Ceponis J, Sidlauskas V, DaugintytePetrusiene L, Norkus A, Zilaitiene B. Factors associated with the prevalence of thyroid nodules and goiter in middle-aged euthyroid subjects. Int J Endocrinol. 2017;2017:8401518. Konturek A, Barczyński M, Cichoń S, PituchNoworolska A, Jonkisz J, Cichoń W. Significance of vascular endothelial growth factor and epidermal growth factor in development of papillary thyroid cancer. Langenbecks Arch Surg. 2005;390:216- 221. Knauf JA. Does the epidermal growth factor receptor play a role in the progre